Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Hillhouse Capital Advisors

Latest statistics and disclosures from Hhlr Advisors's latest quarterly 13F-HR filing:

Top 5 stock holdings are PDD, BABA, ONC, FUTU, LEGN, and represent 87.76% of Hhlr Advisors's stock portfolio.
Added to shares of these 8 stocks: BABA (+$314M), PDD (+$241M), TSM, GOOGL, IBIT, AXIA, VNET, AXIA.PC.
Started 6 new stock positions in AXIA, GOOGL, VNET, TSM, IBIT, AXIA.PC.
Reduced shares in these 9 stocks: FUTU (-$264M), BIDU (-$216M), BULL (-$211M), , YMM (-$53M), SE (-$32M), AVBP (-$11M), EM (-$5.3M), BEDU.
Sold out of its positions in BIDU, BEDU, YMM, NTES, SE, EM.
Hhlr Advisors was a net seller of stock by $-350M.
Hhlr Advisors has $3.1B in assets under management (AUM), dropping by -24.13%.
Central Index Key (CIK): 0001762304

Tip: Access up to 7 years of quarterly data

Positions held by Hillhouse Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Hhlr Advisors

Hhlr Advisors holds 33 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Pdd Holdings Sponsored Ads (PDD)	39.2	$1.2B	+24%	11M	113.39	View chart
Alibaba Group Hldg Sponsored Ads (BABA)	25.6	$796M	+65%	5.4M	146.58	View chart
Beone Medicines Sponsored Ads (ONC)	10.1	$314M		1.0M	303.81	View chart
Futu Hldgs Spon Ads Cl A (FUTU)	8.6	$268M	-49%	1.6M	164.21	View chart
Legend Biotech Corp Sponsored Ads (LEGN)	4.2	$130M		6.0M	21.74	View chart
Arrivent Biopharma (AVBP)	2.5	$79M	-12%	3.9M	20.12	View chart
Ke Hldgs Sponsored Ads (BEKE)	2.2	$67M		4.2M	15.76	View chart
Webull Corp Ord Shs (BULL)	1.5	$46M	-81%	6.0M	7.77	View chart
Cytek Biosciences (CTKB)	1.1	$34M		6.7M	5.05	View chart
Clearwater Analytics Hldgs I Cl A (CWAN)	1.1	$33M		1.4M	24.12	View chart
Novabridge Biosciences Sponsored Ads (NBP)	0.8	$24M		6.0M	3.98	View chart
Yatsen Hldg Sponsored Ads (YSG)	0.6	$19M		4.9M	3.89	View chart
Maze Therapeatics (MAZE)	0.6	$19M		458k	41.43	View chart
Gossamer Bio (GOSS)	0.5	$15M		5.0M	3.10	View chart
Agora Ads (API)	0.3	$8.5M		2.1M	4.07	View chart
Contineum Therapeutics Cl A (CTNM)	0.2	$7.7M		669k	11.43	View chart
Sagimet Biosciences Com Ser A (SGMT)	0.1	$4.3M		725k	5.92	View chart
Taiwan Semiconductor Mfg Sponsored Ads (TSM)	0.1	$3.4M	NEW	11k	303.89	View chart
Tuya Sponsered Ads (TUYA)	0.1	$3.3M		1.6M	2.11	View chart
Ge Aerospace Com New (GE)	0.1	$3.1M		10k	308.03	View chart
Alphabet Cap Stk Cl A (GOOGL)	0.1	$2.3M	NEW	7.3k	313.00	View chart
Mogu Spon Ads (MOGU)	0.1	$1.8M		848k	2.13	View chart
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)	0.1	$1.8M	NEW	35k	49.65	View chart
Pacific Biosciences of California (PACB)	0.1	$1.7M		919k	1.87	View chart
Moody's Corporation (MCO)	0.0	$1.5M		2.9k	510.85	View chart
Equinox Gold Corp equities (EQX)	0.0	$1.1M		81k	14.04	View chart
Barrick Mng Corp Com Shs (B)	0.0	$1.1M		25k	43.55	View chart
Centrais Elet Bras Sa Sponsored Adr (AXIA)	0.0	$885k	NEW	97k	9.16	View chart
Aligos Therapeutics Com New (ALGS)	0.0	$711k		76k	9.32	View chart
Vnet Group Sponsored Ads A (VNET)	0.0	$449k	NEW	53k	8.46	View chart
Centrais Elet Bras Sa Spon Ads Pf Cl C (AXIA.PC)	0.0	$219k	NEW	25k	8.62	View chart
Uxin Sponsored Ads (UXIN)	0.0	$65k		19k	3.37	View chart
Ridgetech Shs New (RDGT)	0.0	$58k		20k	2.85	View chart

Past Filings by Hhlr Advisors

SEC 13F filings are viewable for Hhlr Advisors going back to 2018

Hhlr Advisors 2025 Q4 filed Feb. 17, 2026
Hhlr Advisors 2025 Q3 filed Nov. 14, 2025
Hhlr Advisors 2025 Q2 filed Aug. 14, 2025
Hhlr Advisors 2025 Q1 filed May 15, 2025
Hhlr Advisors 2024 Q4 filed Feb. 14, 2025
Hhlr Advisors 2024 Q3 filed Nov. 14, 2024
Hhlr Advisors 2024 Q2 filed Aug. 14, 2024
Hhlr Advisors 2024 Q1 filed May 14, 2024
Hhlr Advisors 2023 Q4 filed Feb. 14, 2024
Hhlr Advisors 2023 Q3 filed Nov. 14, 2023
Hhlr Advisors 2023 Q2 filed Aug. 14, 2023
Hhlr Advisors 2023 Q1 filed May 15, 2023
Hhlr Advisors 2022 Q4 filed Feb. 14, 2023
Hhlr Advisors 2022 Q3 filed Nov. 14, 2022
Hhlr Advisors 2022 Q2 filed Aug. 15, 2022
Hhlr Advisors 2022 Q1 filed May 16, 2022

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z